AI companies such as OpenAI and Anthropic have long focused on building tools that can write code that will speed up software ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Cornered in a part of Downtown Los Angeles swamped in contemporary art museums and performance centers, REDCAT has become a ...

The Great Flood starts out as a very compelling disaster movie, but it almost becomes a disaster of a movie on the back of its own confounding ambition. It’s also the critics’ least favourite movie to ...

One of the key learning outcomes of university education in general, and liberal arts programmes,  in particular, is that ...

This article, presented in the backdrop of the debates on the state of political theory in India, argues that the terms of debate need to shift to include the question of method of doing political ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Calling consciousness an "entropic engine" points to something psychologically obvious: selfhood costs energy. Maintaining a stable "me" model across time, contexts, and internal contradictions ...

Experts detail the benefits of swimming, from strengthening your muscles to reducing inflammation and boosting your mental health—and how to get started. Swimming offers a low-impact exercise with ...

Palantir has been one of the best growth stories in the market. UiPath is just beginning to see its revenue growth accelerate ...